Gambia vs Kyrgyzstan: Number of clinical trials
Gambia
3 trials
in 2022
Kyrgyzstan
3 trials
in 2023
Gambia rank
95th
Kyrgyzstan rank
95th
Number of clinical trials over time
- Gambia
- Kyrgyzstan
How they compare
Gambia currently reports 3 trials against 3 trials in Kyrgyzstan, a difference of 0 trials.
The two have swapped places 6 times across 9 shared years of data; in 2013 it was Gambia ahead.
Gambia ranks 95th and Kyrgyzstan ranks 95th of 153 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Gambia | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.33 trials | 4 trials | 0.6667 trials | Kyrgyzstan |
| 2020s | 2 trials | 1.33 trials | 0.6667 trials | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Gambia or Kyrgyzstan?
- Gambia, at 3 trials against 3 trials in Kyrgyzstan as of 2022.
- What is the difference in number of clinical trials between Gambia and Kyrgyzstan?
- 0 trials, with Gambia ahead.
- How many years of comparable data are there for Gambia and Kyrgyzstan?
- 9 years are reported by both, from 2013 to 2022.
- How do Gambia and Kyrgyzstan rank globally for number of clinical trials?
- Gambia ranks 95th and Kyrgyzstan ranks 95th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.